Literature DB >> 6517975

Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity. A case report.

Y Matsuzawa, S Yamashita, K Kameda, M Kubo, S Tarui, I Hara.   

Abstract

We report here a peculiar case with premature corneal opacity and extremely high levels of HDL cholesterol in serum. The patient is a 54-year-old man who was first noticed to have marked corneal opacities at age 19. His serum HDL cholesterol level was elevated to the level of 135-160 mg/dl, while total serum cholesterol and triglyceride concentrations were 254 mg/dl and 56 mg/dl, respectively. Serum apoprotein A-I and E levels analyzed by single radial immunodiffusion method were elevated in the case. Serum lipoprotein fractions isolated by preparative ultracentrifugation revealed that increased levels of HDL cholesterol were accounted for solely by the HDL2 fraction. HDL2 of the patient contained relatively higher amounts of apoprotein E than normal control HDL2. Elution profiles of lipoproteins in high performance liquid chromatography revealed that HDL2 particles from the patient were larger in size than those from normal controls. These characteristics of HDL are in part similar to those of HDLC which appears in experimental animals after cholesterol feeding. Such abnormalities in HDL2 fractions associated with premature corneal opacity have not been reported so far and appear to constitute a new disease entity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6517975     DOI: 10.1016/0021-9150(84)90196-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

1.  Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.

Authors:  S Yamashita; D L Sprecher; N Sakai; Y Matsuzawa; S Tarui; D Y Hui
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

2.  Disease-associated marked hyperalphalipoproteinemia.

Authors:  Ken-Ichi Hirano; Hironori Nagasaka; Kazuhiro Kobayashi; Satoshi Yamaguchi; Akira Suzuki; Tatsushi Toda; Manabu Doyu
Journal:  Mol Genet Metab Rep       Date:  2014-06-30

Review 3.  Primary genetic disorders affecting high density lipoprotein (HDL).

Authors:  Constantine E Kosmas; Delia Silverio; Andreas Sourlas; Frank Garcia; Peter D Montan; Eliscer Guzman
Journal:  Drugs Context       Date:  2018-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.